BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32930122)

  • 21. Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.
    Leung EL; Fiscus RR; Tung JW; Tin VP; Cheng LC; Sihoe AD; Fink LM; Ma Y; Wong MP
    PLoS One; 2010 Nov; 5(11):e14062. PubMed ID: 21124918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered immunoexpression of SOX2, OCT4 and Nanog in the normal-appearing oral mucosa of tobacco users.
    Swain N; Thakur M; Pathak J; Patel S; Hosalkar R; Ghaisas S
    Dent Med Probl; 2022; 59(3):389-395. PubMed ID: 36170598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SOX2 and SOX9 are markers of clinically aggressive disease in metastatic high-grade serous carcinoma.
    Sherman-Samis M; Onallah H; Holth A; Reich R; Davidson B
    Gynecol Oncol; 2019 Jun; 153(3):651-660. PubMed ID: 30904337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Pourbagher R; Akhavan-Niaki H; Jorsaraei SGA; Fattahi S; Sabour D; Zabihi E; Abedian Z; Ghasemi M; Golpour M; Mostafazadeh A
    Gene; 2020 Apr; 734():144381. PubMed ID: 31978510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosstalks between Raf-kinase inhibitor protein and cancer stem cell transcription factors (Oct4, KLF4, Sox2, Nanog).
    Lee S; Wottrich S; Bonavida B
    Tumour Biol; 2017 Apr; 39(4):1010428317692253. PubMed ID: 28378634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-expression of Cancer Stem Cell Markers OCT4 and NANOG Predicts Poor Prognosis in Renal Cell Carcinomas.
    Rasti A; Mehrazma M; Madjd Z; Abolhasani M; Saeednejad Zanjani L; Asgari M
    Sci Rep; 2018 Aug; 8(1):11739. PubMed ID: 30082842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer.
    Liu Y; Zhang C; Fan J; Xiao L; Yin B; Zhou L; Xia S
    World J Surg Oncol; 2011 Oct; 9():121. PubMed ID: 21982273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
    Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
    Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.
    Choi EJ; Seo EJ; Kim DK; Lee SI; Kwon YW; Jang IH; Kim KH; Suh DS; Kim JH
    Oncotarget; 2016 Jan; 7(3):3506-19. PubMed ID: 26654944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.
    Carina V; Zito G; Pizzolanti G; Richiusa P; Criscimanna A; Rodolico V; Tomasello L; Pitrone M; Arancio W; Giordano C
    Thyroid; 2013 Jul; 23(7):829-37. PubMed ID: 23301671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein arginine methyltransferase 7-mediated
    Chen TY; Lee SH; Dhar SS; Lee MG
    J Biol Chem; 2018 Mar; 293(11):3925-3936. PubMed ID: 29378844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased expression of the pluripotency markers sex-determining region Y-box 2 and Nanog homeobox in ovarian endometriosis.
    Song Y; Xiao L; Fu J; Huang W; Wang Q; Zhang X; Yang S
    Reprod Biol Endocrinol; 2014 May; 12():42. PubMed ID: 24884521
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
    Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
    Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
    PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Putative cancer stem cells are present in surgical margins of oral squamous cell carcinoma.
    Lazarevic M; Milosevic M; Trisic D; Toljic B; Simonovic J; Nikolic N; Mikovic N; Jelovac D; Petrovic M; Vukadinovic M; Milasin J
    J BUON; 2018; 23(6):1686-1692. PubMed ID: 30610795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the Effect of Orlistatorlistat on Expression of OCT4, Nanog, SOX2, and KLF4 Genes in Colorectal Cancer SW40 Cell Line.
    Noroozi Karimabad M; Roostaei F; Mahmoodi M; Hajizadeh MR
    Asian Pac J Cancer Prev; 2021 Aug; 22(8):2335-2341. PubMed ID: 34452543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.
    Murakami A; Takahashi F; Nurwidya F; Kobayashi I; Minakata K; Hashimoto M; Nara T; Kato M; Tajima K; Shimada N; Iwakami S; Moriyama M; Moriyama H; Koizumi F; Takahashi K
    PLoS One; 2014; 9(1):e86459. PubMed ID: 24489728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification and characterization of cells with cancer stem cell properties in human primary lung cancer cell lines.
    Wang P; Gao Q; Suo Z; Munthe E; Solberg S; Ma L; Wang M; Westerdaal NA; Kvalheim G; Gaudernack G
    PLoS One; 2013; 8(3):e57020. PubMed ID: 23469181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
    Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
    Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.